Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 198

Similar articles for PubMed (Select 21679419)

1.

Herpes zoster in Germany: quantifying the burden of disease.

Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O.

BMC Infect Dis. 2011 Jun 16;11:173. doi: 10.1186/1471-2334-11-173.

2.

Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.

Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O.

BMC Health Serv Res. 2013 Sep 26;13:359. doi: 10.1186/1472-6963-13-359.

3.

Cost effectiveness of herpes zoster vaccine in Canada.

Najafzadeh M, Marra CA, Galanis E, Patrick DM.

Pharmacoeconomics. 2009;27(12):991-1004. doi: 10.2165/11314010-000000000-00000.

PMID:
19908924
4.

Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.

de Boer PT, Pouwels KB, Cox JM, Hak E, Wilschut JC, Postma MJ.

Vaccine. 2013 Feb 18;31(9):1276-83. doi: 10.1016/j.vaccine.2012.12.067. Epub 2013 Jan 8.

PMID:
23306360
5.

Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.

Ultsch B, Köster I, Reinhold T, Siedler A, Krause G, Icks A, Schubert I, Wichmann O.

Eur J Health Econ. 2013 Dec;14(6):1015-26. doi: 10.1007/s10198-012-0452-1. Epub 2012 Dec 28.

PMID:
23271349
6.

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Pellissier JM, Brisson M, Levin MJ.

Vaccine. 2007 Nov 28;25(49):8326-37. Epub 2007 Oct 17.

PMID:
17980938
7.

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.

Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A.

BMC Infect Dis. 2010 Aug 3;10:230. doi: 10.1186/1471-2334-10-230.

8.

A systematic review of the cost effectiveness of herpes zoster vaccination.

Szucs TD, Pfeil AM.

Pharmacoeconomics. 2013 Feb;31(2):125-36. doi: 10.1007/s40273-012-0020-7. Review.

PMID:
23335045
9.

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.

Brisson M, Pellissier JM, Camden S, Quach C, De Wals P.

Hum Vaccin. 2008 May-Jun;4(3):238-45. Epub 2010 May 25.

10.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Hornberger J, Robertus K.

Ann Intern Med. 2006 Sep 5;145(5):317-25.

PMID:
16954357
11.

[Herpes Zoster and its prevention in Italy. Scientific consensus statement].

Franco E, Gabutti G, Bonanni P, Conversano M, Stefano Valente ME, Ferro A, Icardi G, Antonio Volpi ML, Maggi S, Rossi A, Scotti S, Vitale F, Greco D; Italian Universities and Epidemiology.

Ig Sanita Pubbl. 2014 Jan-Feb;70(1):111-27. Italian.

PMID:
24770367
12.

Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.

Johnson RW.

Aging Clin Exp Res. 2009 Jun;21(3):236-43. Review.

PMID:
19571648
13.

Vaccination: a new option to reduce the burden of herpes zoster.

Mick G.

Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32. Review.

PMID:
20192716
14.
15.

Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

White RR, Lenhart G, Singhal PK, Insinga RP, Itzler RF, Pellissier JM, Segraves AW.

Pharmacoeconomics. 2009;27(9):781-92. doi: 10.2165/11317560-000000000-00000.

PMID:
19757871
16.

Vaccination against Herpes Zoster and Postherpetic Neuralgia.

Oxman MN, Levin MJ; Shingles Prevention Study Group.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S228-36. doi: 10.1086/522159.

17.

Incidence of herpes zoster and its complications in Germany, 2005-2009.

Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E.

J Infect. 2015 Feb;70(2):178-86. doi: 10.1016/j.jinf.2014.08.018. Epub 2014 Sep 16.

PMID:
25230396
18.

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands.

van Lier A, van Hoek AJ, Opstelten W, Boot HJ, de Melker HE.

BMC Health Serv Res. 2010 Aug 13;10:237. doi: 10.1186/1472-6963-10-237.

19.

Herpes zoster and postherpetic neuralgia in Catalonia (Spain).

Salleras L, Salleras M, Salvador P, Soldevila N, Prat A, Garrido P, Domínguez A.

Hum Vaccin Immunother. 2015;11(1):178-84. doi: 10.4161/hv.34421. Epub 2014 Nov 1.

PMID:
25483532
20.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Rothberg MB, Virapongse A, Smith KJ.

Clin Infect Dis. 2007 May 15;44(10):1280-8. Epub 2007 Apr 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk